MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-JH-06-0022481
Oviat Pharmaceuticals Private Limited - pharma in Jamshedpur, Jharkhand, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.74 Cr
▲ 53% YoY
Net profit · FY 2024
₹12.45 Lakh
Net margin 4.5%
EBITDA · FY 2024
₹25.23 Lakh
EBITDA margin 9.2%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Open charges
₹1.11 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About Oviat Pharmaceuticals Private Limited
Data last updated:
Oviat Pharmaceuticals Private Limited is a private limited company based in Jamshedpur, Jharkhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U36999JH2017PTC009752. Its GSTIN is 20AACCO4623Q1ZE (Jharkhand).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Sandeep Mukherjee and Anita Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Line No. 5 H No. 7 Anand Nagar Namda Basti Golmuri, Jamshedpur, Jharkhand, India – 831003.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.74 Cr, a growth of 53% compared to the previous year. For the same year it recorded a net profit of ₹12.45 Lakh (net margin 4.5%) and EBITDA of ₹25.23 Lakh (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 78% over three years and 57% over five years.
As per MCA filings, the company has open charges of ₹1.11 Cr on record.
Oviat Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JH-06-0022481). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website oviatpharma.com.
Company details
CIN U36999JH2017PTC009752
Registration Number 009752
Incorporation Date 14 March 2017
ROC Ranchi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-JH-06-0022481
Key People
Sandeep Mukherjee Director Anita Kumari Director Recognitions & Rankings of Oviat Pharmaceuticals
Contact details
Oviat Pharmaceuticals Private Limited's registered office is in Jamshedpur, Jharkhand. Its website is oviatpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressLine No. 5 H No. 7 Anand Nagar Namda Basti Golmuri, Jamshedpur, Jharkhand, India – 831003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Oviat Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Oviat Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Oviat Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Oviat Pharmaceuticals Private Limited, buy the company report.
Financials of Oviat Pharmaceuticals Private Limited
FY 2025 filings availableOviat Pharmaceuticals Private Limited reported revenue of ₹2.74 Cr (up 53% YoY) for FY 2024.
Revenue · FY 2024
₹2.74 Cr ▲ 53%
Net profit · FY 2024
₹12.45 Lakh margin 4.5%
EBITDA · FY 2024
₹25.23 Lakh margin 9.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 53%
3 years · compounded
▲ 78%
5 years · compounded
▲ 57%
EBITDA CAGR growth
1 year
▲ 150%
3 years · compounded
▲ 171%
5 years · compounded
▲ 84%
Revenue has grown at a compounded annual rate (CAGR) of 57% over five years, including 53% growth in the latest year. EBITDA rose 150% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.23 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.2% | ||||
| Net Profit Margin | 4.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oviat Pharmaceuticals Private Limited, buy the company report.
Board of directors of Oviat Pharmaceuticals Private Limited
Oviat Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Mukherjee Also directs: Opulent Touch Interiors LLP | Director | 19 Jan 2019 | 7 Years 9 Months | Current |
| Anita Kumari Also directs: Opulent Touch Interiors LLP | Director | 14 Mar 2017 | 9 Years 7 Months | Current |
Peer comparison
Oviat Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neelkanth Medicare Private Limited | ₹2.75 Cr (FY 2025) | 24.0% | New Delhi, Delhi, India | |||
| Globerian Pharma Private Limited | ₹2.75 Cr (FY 2025) | 5007.0% | Panchkula, Haryana, India | |||
| Cicerone Technologies Private Limited | ₹2.75 Cr (FY 2025) | 20.0% | Gurugram, Haryana, India | |||
| Poss Multitrade Private Limited | ₹2.75 Cr (FY 2022) | -42.0% | Mumbai, Maharashtra, India | |||
| Oviat Pharmaceuticals Private Limitedthis company | ₹2.74 Cr (FY 2024) | ₹12.45 Lakh | 4.5% | 53.0% | Jamshedpur, Jharkhand, India | |
| Raybros Medicaments Private Limited | ₹2.74 Cr (FY 2024) | -2.0% | Mumbai, Maharashtra, India | |||
| Blaine Pharmaceuticals Private Limited | ₹2.73 Cr (FY 2024) | 25.0% | Haridwar, Uttarakhand, India | |||
| Health Care (India) Limited | ₹2.73 Cr (FY 2024) | -98.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Oviat Pharmaceuticals Private Limited, buy the company report.
Auditor
Oviat Pharmaceuticals Private Limited is audited by B KHEMKA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B KHEMKA & ASSOCIATES | FY 2022 | 010112C |
Shareholding
The shareholding of Oviat Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Oviat Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.11 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Jun 2024 | 100942882 | Others | ₹17.5 Lakh | Open | |
| 01 Jun 2024 | 100939290 | State Bank of India | ₹50 Lakh | Open | |
| 04 Apr 2024 | 100902972 | Others | ₹16 Lakh | Open | |
| 16 Feb 2023 | 100683410 | Others | ₹27 Lakh | Open |
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Oviat Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oviat Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oviat Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AACCO4623Q1ZE | Jharkhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Oviat Pharmaceuticals Private Limited, buy the company report.
Recent activity
Oviat Pharmaceuticals Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Manish Kumar ceased to be Director on 18 Mar 2024.
AGM
Oviat Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Oviat Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ranchi.
Charges
A charge with Others amounted to Rs. 17.50 Lakh with Charge ID 100942882 was registered on 13 Jun 2024.
Charges
A charge with State Bank Of India amounted to Rs. 50.00 Lakh with Charge ID 100939290 was registered on 01 Jun 2024.
Charges
A charge with Others amounted to Rs. 16.00 Lakh with Charge ID 100902972 was registered on 04 Apr 2024.
Ceased
Manish Kumar ceased to be Director.
Charges
A charge with Others amounted to Rs. 27.00 Lakh with Charge ID 100683410 was registered on 16 Feb 2023.
Ceased
Sandeep Mukherjee ceased to be Additional Director.
Appointed
Sandeep Mukherjee was appointed as Director.
Appointed
Anita Kumari was appointed as Director.
Incorporation
14 Mar 2017
Oviat Pharmaceuticals Private Limited was registered on 14 Mar 2017 with Roc Ranchi & aged 9 years 8 months as per MCA records.
Frequently asked questions
Oviat Pharmaceuticals is an active private limited company based in Jamshedpur, Jharkhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 March 2017 (9+ years old) and is registered under CIN U36999JH2017PTC009752.
Oviat Pharmaceuticals has 2 current directors:
- Sandeep Mukherjee - Director
- Anita Kumari - Director
The latest financial statements of Oviat Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Oviat Pharmaceuticals is 20AACCO4623Q1ZE, registered in Jharkhand.
The CIN (Corporate Identification Number) of Oviat Pharmaceuticals is U36999JH2017PTC009752. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oviat Pharmaceuticals was incorporated on 14 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Oviat Pharmaceuticals by revenue are Neelkanth Medicare Private Limited, Globerian Pharma Private Limited, Cicerone Technologies Private Limited, Poss Multitrade Private Limited, Raybros Medicaments Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Manish Kumar ceased to be Director on 18 Mar 2024. Sandeep Mukherjee ceased to be Additional Director on 30 Sep 2019. Sandeep Mukherjee was appointed as Director on 19 Jan 2019. Oviat Pharmaceuticals has 4 board changes on record in total.
Yes, Oviat Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JH-06-0022481).
Oviat Pharmaceuticals can be reached through the website oviatpharma.com. Its registered office is in Jamshedpur, Jharkhand, India.
The registered office of Oviat Pharmaceuticals is at Line No. 5 H No. 7 Anand Nagar Namda Basti Golmuri, Jamshedpur, Jharkhand, India – 831003.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages